Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study> GIAS | 2015 | PublicacionesAutor: Muga R y otrosRevista: BMC Infect DisFuente: Pubmed/25231321 Volver a Publicaciones ← Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and phase II metabolites, including a novel succinyl conjugate Emerging drugs in Europe →
